TABLE 2.
Prognostic Factors for Clinical Worsening in CTD-PAH
| Baseline Assessment | Final Assessment | |||||||
|---|---|---|---|---|---|---|---|---|
| Univariate Analysis | Multivariate Analysis | Univariate Analysis | Multivariate Analysis | |||||
| HR (95% CI) | p value | HR (95% CI) | p value | HR (95% CI) | p value | HR (95% CI) | p value | |
| Clinical worsening | ||||||||
| mPAP | 1.07 (1.01–1.14) | 0.022 | 1.15 (1.01–1.31) | 0.027 | ||||
| Hb | 0.53 (0.36–0.79) | 0.002 | 0.54 (0.36–0.80) | 0.002 | ||||
| ESR 60 min | 1.03 (1.01–1.05) | 0.011 | 1.05 (1.01–1.09) | 0.007 | ||||
| qR | 4.24 (1.17–15.45) | 0.028 | 0.03 (0.00–0.33) | 0.004 | ||||
qR patterns in ECG. See Supplementary Table 3 for all statistic results.